PHH Investments Ltd. lowered its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 0.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,741 shares of the medical instruments supplier’s stock after selling 60 shares during the period. PHH Investments Ltd.’s holdings in Becton, Dickinson and were worth $1,237,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Guardian Life Insurance Co. of America increased its position in shares of Becton, Dickinson and by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 819 shares of the medical instruments supplier’s stock worth $150,000 after buying an additional 6 shares during the last quarter. Wellington Shields & Co. LLC increased its position in shares of Becton, Dickinson and by 0.3% in the first quarter. Wellington Shields & Co. LLC now owns 2,534 shares of the medical instruments supplier’s stock worth $465,000 after buying an additional 8 shares during the last quarter. Parkside Financial Bank & Trust increased its position in shares of Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock worth $116,000 after buying an additional 9 shares during the last quarter. Capital Investment Advisors LLC increased its position in shares of Becton, Dickinson and by 0.7% in the first quarter. Capital Investment Advisors LLC now owns 2,412 shares of the medical instruments supplier’s stock worth $442,000 after buying an additional 17 shares during the last quarter. Finally, North Star Investment Management Corp. increased its position in shares of Becton, Dickinson and by 3.4% in the first quarter. North Star Investment Management Corp. now owns 549 shares of the medical instruments supplier’s stock worth $101,000 after buying an additional 18 shares during the last quarter. Institutional investors and hedge funds own 75.57% of the company’s stock.

Becton, Dickinson and Company (NYSE:BDX) traded up 0.04% during mid-day trading on Wednesday, reaching $201.57. 276,026 shares of the company’s stock traded hands. The stock has a market cap of $45.87 billion, a P/E ratio of 58.38 and a beta of 1.05. The firm has a 50-day moving average price of $199.29 and a 200-day moving average price of $188.36. Becton, Dickinson and Company has a 1-year low of $161.29 and a 1-year high of $206.63.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The business had revenue of $3.04 billion during the quarter, compared to analysts’ expectations of $3.06 billion. During the same period last year, the business earned $2.35 earnings per share. The firm’s revenue was down 5.1% on a year-over-year basis. Equities research analysts anticipate that Becton, Dickinson and Company will post $9.46 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be paid a $0.73 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.92 annualized dividend and a dividend yield of 1.45%. Becton, Dickinson and’s dividend payout ratio is presently 83.43%.

ILLEGAL ACTIVITY WARNING: “Becton, Dickinson and Company (BDX) Position Lowered by PHH Investments Ltd.” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.watchlistnews.com/becton-dickinson-and-company-bdx-position-lowered-by-phh-investments-ltd/1495899.html.

BDX has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 price objective on the stock in a research report on Monday, July 17th. Raymond James Financial, Inc. raised shares of Becton, Dickinson and from an “outperform” rating to a “strong-buy” rating and lowered their price objective for the company from $210.00 to $180.00 in a research report on Friday, June 30th. BidaskClub raised shares of Becton, Dickinson and from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 11th. Cowen and Company reaffirmed a “buy” rating and set a $230.00 price objective on shares of Becton, Dickinson and in a research report on Monday. Finally, Bank of America Corporation reaffirmed a “buy” rating and set a $225.00 price objective (up from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. Becton, Dickinson and presently has an average rating of “Buy” and an average target price of $195.79.

In related news, EVP Ribo Alberto Mas sold 7,463 shares of the firm’s stock in a transaction on Monday, August 14th. The shares were sold at an average price of $201.41, for a total value of $1,503,122.83. Following the completion of the transaction, the executive vice president now directly owns 29,323 shares of the company’s stock, valued at $5,905,945.43. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas E. Polen, Jr. sold 5,971 shares of the firm’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the completion of the transaction, the insider now directly owns 12,861 shares of the company’s stock, valued at $2,538,890.01. The disclosure for this sale can be found here. Insiders sold 51,482 shares of company stock valued at $9,871,556 over the last three months. 1.40% of the stock is owned by company insiders.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.